News

Scientists engineered stem cells to better understand the mechanisms behind a form of leukemia caused by changes in a key gene, according to a study led by Mount Sinai researchers.

The HudsonAlpha Institute for Biotechnology has received a $100,000 grant from the Jane K. Lowe Charitable Foundation to help establish a clinical genomics program for patients in Alabama and beyond.

Scientists have gained a key insight into how prostate tumors get their start – not by rewriting the normal DNA code, but by reprogramming the master regulator of genes in prostate cells to drive malignant growth.

A coalition of leukemia researchers led by scientists from UC San Francisco has discovered surprising genetic diversity in juvenile myelomonocytic leukemia (JMML), a rare but aggressive childhood blood cancer.

A family’s diagnosis helps drive discovery to slow decline in muscle function.

Mouse study suggests genomic screening before treatment may help prevent anemia.

The malaria parasite molecules associated with severe disease and death--those that allow the parasite to escape recognition by the immune system--have been shown to share key gene segments with chimp and gorilla malaria parasites

A surprising, paradoxical relationship between a tumor suppressor molecule and an oncogene may be the key to explaining and working around how breast cancer tumor cells become desensitized to a common cancer drug, found researchers at the Perelman School of Medicine at the University of Pennsylvania.

Growing insights about a significant, yet poorly understood, part of the genome – the “dark matter of DNA” -- have fundamentally changed the way scientists approach the study of diseases.

Researchers at BGU and the Massachusetts Institute of Technology (MIT) have developed a highly sensitive, cost-effective technology for rapid bacterial pathogen screening of air, soil, water, and agricultural produce in as little as 24 hours.